Skip to content
10-Q

Quarterly Report

EMERGE HEALTH INTERNATIONAL INC

0001477932-19-000755

← back to feed
Filed
Mar 1, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Mar 1, 2019 17.77M sh
Operating Cash Flow Q2 2017 · Dec 31, 2016 −$22.89K
Operating Cash Flow Q2 2017 · Dec 31, 2015 −$177.75K
Stockholders Equity Q2 2017 · Dec 31, 2016 $1.09M
Stockholders Equity Q2 2017 · Jun 30, 2016 $1.03M
Current Liabilities Q2 2017 · Dec 31, 2016 $228.31K
Current Liabilities Q2 2017 · Jun 30, 2016 $280.98K
Total Liabilities Q2 2017 · Dec 31, 2016 $234.19K
Total Liabilities Q2 2017 · Jun 30, 2016 $280.98K
Current Assets Q2 2017 · Dec 31, 2016 $812.3K
Current Assets Q2 2017 · Jun 30, 2016 $784.47K
Total Assets Q2 2017 · Dec 31, 2016 $1.33M
Total Assets Q2 2017 · Jun 30, 2016 $1.31M
Rd Expense Q2 2017 · Dec 31, 2016 $0
Rd Expense restated Q2 2017 · Dec 31, 2015 $1.5K
Capex Q2 2017 · Dec 31, 2015 $21.73K
Cash And Equivalents Q2 2017 · Dec 31, 2015 $36.17K
Cash And Equivalents Q2 2017 · Jun 30, 2015 $100.43K
Eps Basic Q2 2017 · Dec 31, 2015 $0.00
Eps Basic Q2 2017 · Dec 31, 2015 $0.00
Net Income restated Q2 2017 · Dec 31, 2015 −$3.54K
Net Income Q2 2017 · Dec 31, 2015 −$22.84K
Operating Income Q2 2017 · Dec 31, 2015 −$35.71K
Operating Income Q2 2017 · Dec 31, 2015 −$57.16K
Gross Profit Q2 2017 · Dec 31, 2015 $160.46K
Gross Profit Q2 2017 · Dec 31, 2015 $369.48K
Cost Of Revenue Q2 2017 · Dec 31, 2015 $188.72K
Cost Of Revenue Q2 2017 · Dec 31, 2015 $479.17K
Revenue Q2 2017 · Dec 31, 2015 $349.18K
Revenue Q2 2017 · Dec 31, 2015 $848.65K